» Authors » Peace Habomugisha

Peace Habomugisha

Explore the profile of Peace Habomugisha including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 28
Citations 395
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jacob B, Loum D, Munu D, Lakwo T, Byamukama E, Habomugisha P, et al.
Am J Trop Med Hyg . 2021 Jan; 104(4):1394-1403. PMID: 33432900
Onchocerciasis, caused by infection with Onchocerca volvulus, has been targeted for elimination by 2030. Currently, onchocerciasis elimination programs rely primarily on mass distribution of ivermectin. However, ivermectin alone may not...
2.
Katabarwa M, Habomugisha P, Khainza A, Oguttu D, Byamukama E, Katamanywa J, et al.
Am J Trop Med Hyg . 2020 Jun; 103(3):1135-1142. PMID: 32588807
Wambabya-Rwamarongo onchocerciasis focus is one of the eight foci Uganda verified using the WHO verification guidelines. The approach for elimination was twice yearly treatment with ivermectin for every round, treating...
3.
Katabarwa M, Habomugisha P, Khainza A, Oguttu D, Byamukama E, Katamanywa J, et al.
Am J Trop Med Hyg . 2020 Apr; 102(6):1411-1416. PMID: 32228786
Uganda has verified elimination of seven onchocerciasis foci since 2007 when the nationwide onchocerciasis elimination policy was launched. However, the Victoria Nile focus (which was eliminated in the early 1970s)...
4.
Michael E, Smith M, Singh B, Katabarwa M, Byamukama E, Habomugisha P, et al.
Sci Rep . 2020 Mar; 10(1):4235. PMID: 32144362
Concern is emerging regarding the challenges posed by spatial complexity for modelling and managing the area-wide elimination of parasitic infections. While this has led to calls for applying heterogeneity-based approaches...
5.
Smith M, Bilal S, Lakwo T, Habomugisha P, Tukahebwa E, Byamukama E, et al.
Sci Rep . 2019 Oct; 9(1):15274. PMID: 31649285
Attention is increasingly focusing on how best to accelerate progress toward meeting the WHO's 2030 goals for neglected tropical diseases (NTDs). For river blindness, a major NTD targeted for elimination,...
6.
Loum D, Cozart D, Lakwo T, Habomugisha P, Jacob B, Cupp E, et al.
PLoS Negl Trop Dis . 2019 Jul; 13(7):e0007558. PMID: 31310607
Background: Onchocerciasis, or river blindness, has historically been an important cause of blindness, skin disease and economic disruption in Africa and the Americas. It is caused by the filarial parasite...
7.
Richards F, Nwoke B, Zarroug I, Tukahebwa E, Negussu N, Higazi T, et al.
Infect Dis Poverty . 2019 Jul; 8(1):52. PMID: 31303175
A recent article "Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes" in Infectious Diseases of Poverty claimed that undue...
8.
Katabarwa M, Griswold E, Habomugisha P, Eyamba A, Byamukama E, Nwane P, et al.
Am J Trop Med Hyg . 2019 Mar; 100(5):1208-1215. PMID: 30915956
Mass drug administration (MDA) with ivermectin must reach a high treatment coverage (90% of the eligible population) if onchocerciasis is to be eliminated. Questions have been raised as to whether...
9.
Michael E, Smith M, Katabarwa M, Byamukama E, Griswold E, Habomugisha P, et al.
Nat Commun . 2018 Nov; 9(1):4929. PMID: 30451847
The original version of this Article contained an error in the spelling of Emily Griswold, which was incorrectly given as Emily Grisworld. This error has now been corrected in both...
10.
Michael E, Smith M, Katabarwa M, Byamukama E, Griswold E, Habomugisha P, et al.
Nat Commun . 2018 Oct; 9(1):4324. PMID: 30337529
Stopping interventions is a critical decision for parasite elimination programmes. Quantifying the probability that elimination has occurred due to interventions can be facilitated by combining infection status information from parasitological...